메뉴 건너뛰기
Biological Psychiatry
Volumn 72, Issue 7, 2012, Pages 522-523
Ketamine: The hopes and the hurdles
Author keywords

[No Author keywords available]
Indexed keywords

AMPHETAMINE; CITALOPRAM; IMIPRAMINE; IPRONIAZID; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;
EID: 84866050607     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.07.021     Document Type: Note
Times cited : (9)
References (10)
  • 2
    • 84866040371 scopus 로고    scopus 로고
    • History of CNS drug development
    • A. Kalali, S. Preskorn, J. Kwentus, S. Stahl, Cambridge University Press New York
    • S.H. Preskorn History of CNS drug development A. Kalali, S. Preskorn, J. Kwentus, S. Stahl, Essential CNS Drug Development 2012 Cambridge University Press New York 1 14
    • (2012) Essential CNS Drug Development , pp. 1-14
    • Preskorn, S.H.1
  • 4
    • 0019470426 scopus 로고
    • Pharmacokinetics and analgesic effects of im and oral ketamine
    • I.S. Grant, W.S. Nimmo, J.A. Clements Pharmacokinetics and analgesic effects of IM and oral ketamine Br J Anaesth 53 1981 810 811
    • (1981) Br J Anaesth , vol.53 , pp. 810-811
    • Grant, I.S.1    Nimmo, W.S.2    Clements, J.A.3
  • 5
    • 77954950428 scopus 로고    scopus 로고
    • Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care
    • S.A. Irwin, A. Iglewicz Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care J Palliat Med 13 2010 903 908
    • (2010) J Palliat Med , vol.13 , pp. 903-908
    • Irwin, S.A.1    Iglewicz, A.2
  • 6
    • 76349084738 scopus 로고    scopus 로고
    • Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: A case series
    • G. Paslakis, M. Gilles, A. Meyer-Lindenberg, M. Deuschle Oral administration of the NMDA receptor antagonist S-ketamine as add-on therapy of depression: a case series Pharmacopsychiatry 43 2010 33 35
    • (2010) Pharmacopsychiatry , vol.43 , pp. 33-35
    • Paslakis, G.1    Gilles, M.2    Meyer-Lindenberg, A.3    Deuschle, M.4
  • 7
    • 80155137597 scopus 로고    scopus 로고
    • A comparative evaluation of intranasal midazolam, ketamine and their combination for sedation of young uncooperative pediatric dental patients: A triple blind randomized crossover trial
    • S.K. Bahetwar, R.K. Pandey, A.K. Saksena, G. Chandra A comparative evaluation of intranasal midazolam, ketamine and their combination for sedation of young uncooperative pediatric dental patients: a triple blind randomized crossover trial J Clin Pediatr Dent 35 2011 415 420
    • (2011) J Clin Pediatr Dent , vol.35 , pp. 415-420
    • Bahetwar, S.K.1    Pandey, R.K.2    Saksena, A.K.3    Chandra, G.4
  • 8
    • 79953169802 scopus 로고    scopus 로고
    • Case report: Prehospital use of intranasal ketamine for paediatric burn injury
    • C. Reid, R. Hatton, P. Middleton Case report: prehospital use of intranasal ketamine for paediatric burn injury Emerg Med J 28 2011 328 329
    • (2011) Emerg Med J , vol.28 , pp. 328-329
    • Reid, C.1    Hatton, R.2    Middleton, P.3
  • 9
    • 84863719297 scopus 로고    scopus 로고
    • A randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder
    • L. Ibrahim, N. Diazgranados, L. Jolkovsky, N. Brutsche, D.A. Luckenbaugh, W.J. Herring A randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder J Clin Psychopharmacol 32 2012 551 557
    • (2012) J Clin Psychopharmacol , vol.32 , pp. 551-557
    • Ibrahim, L.1    Diazgranados, N.2    Jolkovsky, L.3    Brutsche, N.4    Luckenbaugh, D.A.5    Herring, W.J.6
  • 10
    • 59049098262 scopus 로고    scopus 로고
    • An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-d-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder
    • S.H. Preskorn, B. Baker, S. Kolluri, F.S. Menniti, M. Krams, J.W. Landen An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-d-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder J Clin Psychopharmacol 28 2008 631 637
    • (2008) J Clin Psychopharmacol , vol.28 , pp. 631-637
    • Preskorn, S.H.1    Baker, B.2    Kolluri, S.3    Menniti, F.S.4    Krams, M.5    Landen, J.W.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.